![](https://themedicinemaker.com/fileadmin/_processed_/2/d/csm_0724-604_NextGen_-_Lovance_Teaser_55bcd45441.png)
TILs Taking on Solid Tumors
Credit: Author supplied In February 2024, the FDA approved the first T-cell therapy for a solid tumor: Amtagvi (lifileucel), developed by Iovance Biotherapeutics. The therapy is indicated for adults with advanced melanoma – after patients have tried other …